Anti-Vascular Endothelial Growth Factor Therapy as an Alternative or Adjunct to Pan-Retinal Photocoagulation in Treating Proliferative Diabetic Retinopathy: Meta-Analysis of Randomized Trials

AIM: To compare anti-vascular growth factor (anti-VEGF) pharmacotherapy with pan-retinal photocoagulation (PRP) for proliferative diabetic retinopathy (PDR). METHOD: PubMed, Embase, Medline, the ClinicalTrials.gov and the Cochrane Central Register of Controlled Trials were reviewed systemically. Ran...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Shuang, Lin, Zhongjing, Shen, Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289996/
https://www.ncbi.nlm.nih.gov/pubmed/32581805
http://dx.doi.org/10.3389/fphar.2020.00849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289996/
https://www.ncbi.nlm.nih.gov/pubmed/32581805
http://dx.doi.org/10.3389/fphar.2020.00849

Ejemplares similares